Agitation, Delirium, and Cognitive Outcomes in Intracerebral Hemorrhage
Overview
Authors
Affiliations
Background: Delirium predicts higher long-term cognitive morbidity. We previously identified a cohort of patients with spontaneous intracerebral hemorrhage and delirium and found worse outcomes in health-related quality of life (HRQoL) in the domain of cognitive function.
Objective: We tested the hypothesis that agitation would have additional prognostic significance on later cognitive function HRQoL.
Methods: Prospective identification of 174 patients with acute intracerebral hemorrhage, measuring stroke severity, agitation, and delirium, with a standardized protocol and measures. HRQoL was assessed using the Neuro-QOL at 28 days, 3 months, and 1 year. Functional outcomes were measured with the modified Rankin Scale.
Results: Among the 81 patients with HRQoL follow-up data available, patients who had agitation and delirium had worse cognitive function HRQoL scores at 28 days (T scores for delirium with agitation 20.9 ± 7.3, delirium without agitation 30.4 ± 16.5, agitation without delirium 36.6 ± 17.5, and neither agitated nor delirious 40.3 ± 15.9; p = 0.03) and at 1 year (p = 0.006). The effect persisted in mixed models after correction for severity of neurologic injury, age, and time of assessment (p = 0.0006) and was not associated with medication use, seizures, or infection.
Conclusions: The presence of agitation with delirium in patients with intracerebral hemorrhage may predict higher risk of unfavorable cognitive outcomes up to 1 year later.
The associations of post-stroke delirium with outcomes: a systematic review and meta-analysis.
Zhang G, Lv J, Yu W, Li H, Wu L, Zhang S BMC Med. 2024; 22(1):470.
PMID: 39407191 PMC: 11475888. DOI: 10.1186/s12916-024-03689-1.
Survivorship After Neurocritical Care: A Scoping Review of Outcomes Beyond Physical Status.
LaBuzetta J, Bongbong D, Mlodzinski E, Sheth R, Trando A, Ibrahim N Neurocrit Care. 2024; 41(2):651-664.
PMID: 38622487 PMC: 11377172. DOI: 10.1007/s12028-024-01965-9.
Neurologic Manifestations of Common Variable Immunodeficiency: Impact on Quality of Life.
De Almeida B, Smith T, Delic A, Esquibel L, Galli J, Millsap L Neurol Neuroimmunol Neuroinflamm. 2023; 10(3).
PMID: 36797058 PMC: 9936420. DOI: 10.1212/NXI.0000000000200088.
Lapin B, Thompson N, Schuster A, Katzan I J Patient Rep Outcomes. 2021; 5(1):53.
PMID: 34228242 PMC: 8260647. DOI: 10.1186/s41687-021-00329-7.
Delirium Assessment in Critically Ill Older Adults: Considerations During the COVID-19 Pandemic.
Duggan M, Van J, Ely E Crit Care Clin. 2020; 37(1):175-190.
PMID: 33190768 PMC: 7427547. DOI: 10.1016/j.ccc.2020.08.009.